contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


scibase-receives-validation-for-nevisense-from-key-opinion-leaders-in-the-us

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Head of Nordic ER Development, Analyst

Antti Luiro

SciBase Holding is a medical technology company. The Group specializes in the management of cancer diagnostics, mainly focused on the treatment and detection of various melanomas. The company has developed an electric handheld probe that analyzes the measurement signal to detect specific changes in the body's skin tissue. The head office is located in Stockholm. 

Scibase Holding

A US expert consensus panel has reviewed new technologies available for melanoma, reviewing results presented in 19 articles. The report by top US clinicians concluded that Nevisense's AI-driven technology can significantly improve the early detection of melanoma.

A US expert consensus panel has <a href="https://www.inderes.se/releases/scibase-new-us-consensus-report-supports-nevisense">reviewed</a> new technologies available for melanoma, reviewing results presented in 19 articles. The report by top US clinicians concluded that Nevisense&apos;s AI-driven technology can significantly improve the early detection of melanoma. Nevisense was mentioned as one of two solutions identified to help accurately diagnose clinically indeterminate lesions. The other solution (GEP-2 test) was at least offered by US-based competitor DermTech, which recently filed for bankruptcy in June.
The press release confirms our view that there appears to be no serious competition for the Nevisense device in skin cancer diagnostics. In addition, as the US is the most critical market for SciBase on its path to cash flow neutrality, the continued good response from key US clinicians should support commercial progress in the market. 
In our view, the main uncertainties in SciBase&apos;s investment case currently relate to factors that are somewhat outside of the company&apos;s control: the timing of the ramp-up of insurance coverage in different states and the speed of adoption of the technology by potential customers. These uncertainties also play into the capital requirements and dilution, which have a significant impact on the return on investment for investors. Therefore, the news does not change our view on the stock and our previous research <a href="https://www.inderes.se/research/scibase-q224-still-waiting-for-more-signals-of-accelerating-growth">report</a> on SciBase remains relevant.

	2023	24e	25e
Revenue	23.2	29.6	45.8
growth-%	29.94 %	27.36 %	54.68 %
EBIT (adj.)	-53.9	-57.8	-48.7
EBIT-% (adj.)	-232.04 %	-195.19 %	-106.25 %
EPS (adj.)	-0.50	-0.30	-0.22
Dividend	0.00	0.00	0.00
Dividend %
P/E (adj.)	-	-	-
EV/EBITDA	-	-	-

SciBase receives validation for Nevisense from key opinion leaders in the US

Scibase Holding

Key Estimate Figures21.08

Scibase Holding

Key Estimate Figures21.08

Stay up to date with our newsletter